• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用恒定变性剂凝胶电泳(CDGE)筛查骨肉瘤中的TP53突变。

Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE).

作者信息

Smith-Sørensen B, Gebhardt M C, Kloen P, McIntyre J, Aguilar F, Cerutti P, Børresen A L

机构信息

Department of Genetics, Norwegian Radium Hospital, Montebello, Oslo.

出版信息

Hum Mutat. 1993;2(4):274-85. doi: 10.1002/humu.1380020407.

DOI:10.1002/humu.1380020407
PMID:8401536
Abstract

We have previously developed conditions to screen for TP53 point mutations inside the conserved domains II-V of the gene by using constant denaturant gel electrophoresis (CDGE). The present study reports conditions for screening more of the codons in the frequently mutated region exon 5-8 and for detecting mutations in sequences encoding functional domains in the N- and C-terminal part of the protein. The ability of the CDGE technique to detect mutations was studied using controls with known sequence deviations. The resolution power of the technique to separate different types of mutations was tested by using seven different single base pair mutants all residing in a stretch of four base pairs. All mutants were separated from the wild type. The established CDGE screening strategy was then used to look for mutations in DNA from 28 osteosarcomas. Six (21.5%) of the samples were shown to have a TP53 mutation, and the exact characterization was performed by direct sequencing. All of these were within the frequently reported mutated region exon 5-8.

摘要

我们之前已开发出相关条件,通过使用恒定变性剂凝胶电泳(CDGE)来筛选基因保守结构域II-V内的TP53点突变。本研究报告了用于筛选更多常见突变区域外显子5-8中密码子以及检测蛋白质N端和C端功能结构域编码序列中突变的条件。利用已知序列偏差的对照研究了CDGE技术检测突变的能力。通过使用均位于一段四个碱基对中的七个不同单碱基对突变体,测试了该技术分离不同类型突变的分辨能力。所有突变体均与野生型分离。然后使用既定的CDGE筛选策略来寻找28例骨肉瘤DNA中的突变。其中六个(21.5%)样本显示存在TP53突变,并通过直接测序进行了精确表征。所有这些突变均在经常报道的突变区域外显子5-8内。

相似文献

1
Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE).使用恒定变性剂凝胶电泳(CDGE)筛查骨肉瘤中的TP53突变。
Hum Mutat. 1993;2(4):274-85. doi: 10.1002/humu.1380020407.
2
Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.用于BRCA1基因突变筛查的变性剂浓度恒定凝胶电泳(CDGE)
Hum Mutat. 1998;11(2):166-74. doi: 10.1002/(SICI)1098-1004(1998)11:2<166::AID-HUMU10>3.0.CO;2-X.
3
High resolution melting for mutation scanning of TP53 exons 5-8.用于TP53基因第5至8外显子突变扫描的高分辨率熔解分析
BMC Cancer. 2007 Aug 31;7:168. doi: 10.1186/1471-2407-7-168.
4
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.恒定变性剂凝胶电泳作为p53突变的快速筛查技术。
Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8405-9. doi: 10.1073/pnas.88.19.8405.
5
Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).使用变性梯度凝胶电泳(DGGE)方法对家族性高胆固醇血症(FH)和家族性载脂蛋白B100缺陷(FDB)患者进行突变筛查。
Malays J Pathol. 2006 Jun;28(1):7-15.
6
Screening for mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophoresis (CDGE).利用聚合酶链反应(PCR)结合恒定变性剂凝胶电泳(CDGE)对人次黄嘌呤磷酸核糖转移酶(HPRT)cDNA中的突变进行筛查。
Mutat Res. 1992 Sep;269(1):41-53. doi: 10.1016/0027-5107(92)90159-y.
7
Development of standard reference materials for diagnosis of p53 mutations: analysis by slab gel single strand conformation polymorphism.用于p53突变诊断的标准参考物质的研制:平板凝胶单链构象多态性分析
Electrophoresis. 1998 Feb;19(2):164-71. doi: 10.1002/elps.1150190206.
8
Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.8例潜在恶性口腔黏膜疾病患者TP53基因突变的纵向研究
J Oral Pathol Med. 2009 Oct;38(9):716-21. doi: 10.1111/j.1600-0714.2009.00767.x. Epub 2009 Mar 14.
9
TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas.TP53突变与I期舌癌的局部区域复发无关。
Anticancer Res. 1999 Jul-Aug;19(4C):3433-8.
10
Analysis of TP53 gene mutations in human lung cancer: comparison of capillary electrophoresis single strand conformation polymorphism assay with denaturing gradient gel electrophoresis and direct sequencing.人类肺癌中TP53基因突变的分析:毛细管电泳单链构象多态性分析与变性梯度凝胶电泳及直接测序的比较
Cancer Detect Prev. 2006;30(1):1-6. doi: 10.1016/j.cdp.2005.10.004. Epub 2006 Feb 3.

引用本文的文献

1
Genetic alterations of triple negative breast cancer (TNBC) in women from Northeastern Mexico.墨西哥东北部女性三阴性乳腺癌(TNBC)的基因改变
Oncol Lett. 2019 Mar;17(3):3581-3588. doi: 10.3892/ol.2019.9984. Epub 2019 Jan 29.
2
Osteosarcoma development and stem cell differentiation.骨肉瘤的发展与干细胞分化。
Clin Orthop Relat Res. 2008 Sep;466(9):2114-30. doi: 10.1007/s11999-008-0335-z. Epub 2008 Jun 18.
3
Characterization of protistan assemblages in the Ross Sea, Antarctica, by denaturing gradient gel electrophoresis.
通过变性梯度凝胶电泳对南极罗斯海原生生物群落进行特征分析。
Appl Environ Microbiol. 2004 Apr;70(4):2028-37. doi: 10.1128/AEM.70.4.2028-2037.2004.
4
Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status.紫杉醇或环磷酰胺联合治疗对上皮性卵巢癌患者的疗效及其与TP53基因状态的关系。
Br J Cancer. 1998 Aug;78(3):375-81. doi: 10.1038/bjc.1998.502.
5
Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families.
Br J Cancer. 1997;75(8):1201-4. doi: 10.1038/bjc.1997.205.
6
Alterations of the p53, Rb and MDM2 genes in osteosarcoma.骨肉瘤中p53、Rb和MDM2基因的改变。
J Cancer Res Clin Oncol. 1996;122(9):559-65. doi: 10.1007/BF01213553.
7
TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material.乳腺癌的TP53突变分析:一项关于石蜡包埋存档材料的研究。
Br J Cancer. 1996 Aug;74(4):555-61. doi: 10.1038/bjc.1996.400.
8
P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.P-糖蛋白在大多数结直肠癌中不表达,且在体内不受突变型p53调控。
Br J Cancer. 1995 Aug;72(2):307-11. doi: 10.1038/bjc.1995.329.